Here are the 8-K filings from VitaNova Life Sciences Corporation (YJGJD) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
An 8-K covers material events a company has to report between its quarterly reports, so if you follow YJGJD and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full YJGJD filings page.
VitaNova Life Sciences Corporation added its Chief Financial Officer, Steve Niu, to the Board of Directors effective February 19, 2026. He will serve as a director until the next annual stockholder meeting or earlier resignation or removal and will not receive additional compensation for this role.
The Board determined that Mr. Niu does not qualify as an independent director under Nasdaq corporate governance standards. He has served as VitaNova’s CFO since January 2024 and previously was President of Triangle Accounting, Inc. from 2001 to 2024, with extensive experience in U.S. and international taxation and regulatory compliance.